The global Myeloma incidence is on the hike for the past three decades. The trends vary with different geographies. However, the low- and middle- income countries reported a consistent increase from 1990 to 2016 in Myeloma incidence and deaths due to Myeloma.
This can be attributed to the lack of standard healthcare facilities in counties that are comparatively lag in socio-economic development. A similar trend has been observed in middle-income countries of the MENA region.
The Middle East and North Africa (MENA) countries have adopted Managed Entry Agreements (MEA) agreement to mitigate the uncertainty regarding the cost, budget and medicine’s relative effectiveness. The adoption of MEA is expected to improve diagnostic and treatment in the MENA region countries.
To read more about Multiple Myeloma visit: https://duphat.ae/multiple-myeloma-a-perky-dynamism/
